𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia

✍ Scribed by Müller-Tidow, C; Metzelder, S K; Buerger, H; Packeisen, J; Ganser, A; Heil, G; Kügler, K; Adigüzel, G; Schwäble, J; Steffen, B

Book ID
110055823
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
362 KB
Volume
18
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aberrant methylation of multiple tumor s
Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia
✍ Cumhur G. Ekmekci; Marina I. Gutiérrez; Abdul K. Siraj; Ugur Ozbek; Kishor Bhati 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 3 views

## Abstract Hypermethylator phenotype, a propensity of tumors to incur nonrandom concurrent methylation, has been described in several tumors, including acute myeloid leukemia (AML). More recent studies identified methylation of other tumor suppressor genes, DAP‐kinase and SOCS1, singly in AML. We

CD7 expression predicts poor disease fre
CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype
✍ Hong Chang; Joanna Yeung; Joseph Brandwein; Qi-long Yi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 215 KB

AML patients with normal karyotype comprise the largest subgroup (∼50%) but have a highly heterogeneous clinical course. By multiparameter flow cytometry we analyzed CD7 expression along with other phenotypic markers in 185 patients with normal-karyotype AML. CD7 was expressed in 68 (37%) patients.